INTRODUCTION
============

Small guanine triphosphate (GTP) ases are well known regulators of diverse cellular and developmental events such as differentiation, cell cycle regulation, vesicle trafficking, microtubule organization, and ribosome assembly *via* GTP-GDP conformational changes. *Caenorhabditis elegans* contains approximately 50 Ras GTPase subfamily genes, including genes of the Ras/Rap/Ral, Rho, Rab, Arf/Sar, and Ran families ([@b26-molcell-37-1-51-8]). *ran-1*, one of the three *ran* genes in *C. elegans*, is a well-characterized nuclear GTPase gene, and functions in nuclear trafficking, nuclear reassembly, and kinetochore association with the mitotic spindle ([@b3-molcell-37-1-51-8]).

Ran is a typical nuclear GTPase that regulates the transportation of transfer RNA, ribosomal subunits, and nuclear localization sequence (NLS) and nuclear export signal (NES) proteins from the cytosol to the nucleus and vice versa. It may directly or indirectly control these transfers through importin, exportin, GTPase activating proteins (GAPs), and guanine exchange factors (GEFs) ([@b22-molcell-37-1-51-8]; [@b31-molcell-37-1-51-8]). More recent reports indicate that Ran may be involved in diverse cytoplasmic events, such as trafficking an ephrin receptor homolog in nematode oocytes, controlling neurite outgrowth in *Drosophila* and in mammalian neurons, and retrograde signaling in nerve axons after injury ([@b47-molcell-37-1-51-8]).

NOG1, a nuclear GTP-binding protein, plays a significant role during the later stages of ribosome biogenesis, particularly in 60S ribosome biogenesis ([@b16-molcell-37-1-51-8]). Moreover, NOG1 is highly conserved from yeast to humans, which indicates its essential role in cell viability ([@b14-molcell-37-1-51-8]). According to the results of a proteome-wide project, NOG1 is localized to the nucleus, where it acts as a critical regulator for ribosome maturation in response to nutrient availability ([@b14-molcell-37-1-51-8]; [@b15-molcell-37-1-51-8]; [@b17-molcell-37-1-51-8]). Ribosomal RNAs (rRNAs) and ribosomal proteins (RPs) are synthesized, assembled, and experience maturation during ribosome bio-synthesis ([@b21-molcell-37-1-51-8]; [@b23-molcell-37-1-51-8]; [@b44-molcell-37-1-51-8]). In addition to rRNAs and RPs, several other nuclear and nucleolar proteins are known to participate in ribosome assembly pathways ([@b9-molcell-37-1-51-8]; [@b41-molcell-37-1-51-8]).

Ribosome biogenesis is a highly energy-dependent process related to nutrient availability, and the process is regulated by target of rapamycin (TOR) ([@b36-molcell-37-1-51-8]). TOR up-regulates the transcriptions of rRNAs and mRNAs of RPs in yeast and mammals ([@b8-molcell-37-1-51-8]; [@b11-molcell-37-1-51-8]; [@b29-molcell-37-1-51-8]; [@b40-molcell-37-1-51-8]). Moreover, TOR activity is required for the early and late stages of ribosome maturation in the nucleoplasm and for rRNA processing. Interestingly, TOR is potentially a downstream component in the insulin/insulin-like growth factor (IGF) signaling pathway that is essential for growth and body size ([@b34-molcell-37-1-51-8]). TOR may interact directly or indirectly with insulin/IGF signaling in order to regulate a common set of proteins that are involved in the control of cell growth, such as translation initiation factor 4E-binding protein (4EBP1) and S6 ribosomal protein kinase ([@b38-molcell-37-1-51-8]).

Recently, deletion of genes that either encode 60S subunit proteins or processing factors have been shown to significantly increase yeast lifespan. Moreover, treatment alone of 60S subunit biogenesis inhibitors increases lifespan sufficiently ([@b39-molcell-37-1-51-8]). Furthermore, *C. elegans* with reduced levels of ribosomal protein S6 (translation initiation factor) and some ribosomal subunits showed an increase in longevity, which may be the result of increased stress resistance ([@b12-molcell-37-1-51-8]; [@b35-molcell-37-1-51-8]). Therefore, it is postulated that NOG1 might modulate longevity *via* ribosomal biogenesis regulation.

Insulin/IGF signaling regulates larval development and adult life span in *C. elegans* ([@b19-molcell-37-1-51-8]; [@b20-molcell-37-1-51-8]). In addition, the TOR pathway in *C. elegans* is known to interact with the insulin signaling pathway to regulate larval development, metabolism, and life span ([@b18-molcell-37-1-51-8]). TOR was also found to be involved in controlling ribosome biogenesis *via* NOG1 in *Saccharomyces cerevisiae* ([@b14-molcell-37-1-51-8]). In *C. elegans*, T07A9.9 was identified as a novel ortholog of *NOG1* (hereafter *NOG-1*). Therefore, we hypothesize that in *C. elegans*, nucleolar GTPase NOG-1 regulates development and life span through the insulin/IGF signaling pathway and/or the TOR signaling pathway. Our results suggest a plausible genetic interaction of *nog-1* with both insulin/IGF and TOR signaling. Furthermore, NOG-1 may play an important role in development and longevity in *C. elegans*.

MATERIALS AND METHODS
=====================

Strains and culture conditions
------------------------------

The wild-type Bristol N2, *daf-16(mu86), sir-2.1(ok434)* were obtained from the *Caenorhabditis* Genetics Center (CGC) at the University of Minnesota. The maintenance of *C. elegans* was carried out according to protocols from [@b5-molcell-37-1-51-8].

Plasmids and expression studies
-------------------------------

Approximately 1.0 kb of the 5′ upstream region (promoter) of *nog-1* (T07A9.9) was amplified by polymerase chain reaction (PCR), and worm lysate was used as the template. The amplified DNA was cloned into a promoterless green fluorescent protein (GFP) vector, pPD95.77, to generate the *nog-1promoter:: gfp* (*Pnog-1::gfp*) construct. For translation fusion constructs, *nog-1* cDNA was amplified by reverse transcription (RT)-PCR and standard PCR techniques and cloned into the same vector, *nog-1 promoter::nog-1::gfp* (*Pnog-1::nog-1::gfp*). A *nog -1 G225A* construct was obtained by a site-directed mutation using one-step overlap extension PCR ([@b42-molcell-37-1-51-8]).

Microinjection was carried out as previously described ([@b30-molcell-37-1-51-8]). As a transformation marker, a plasmid pRF4 containing a dominant gene (*rol-6*) was co-injected. The transgenic worms were isolated by their rolling pattern and GFP expressions using a NIKON fluorescent stereomicroscope SMZ1000. Images were captured using a Nikon microscope Eclipse 80i-DS-Fi1 system.

For RNAi bacterial feeding constructs, target cDNAs (*gfp, daf-2, daf-16, nog-1,* and *rlp-24.2*) were obtained by RT-PCR and standard PCR techniques, and the cDNAs were cloned into the L4440 Fire vector for bacteria-feeding-mediated RNAi. The RNAi constructs were eventually transformed and maintained in HT115 (DE3) *Escherichia coli* hosts.

*nog-1* and *rlp-24.2* over-expression constructs were generated using a specific heat shock promoter containing vectors (pPD49.83). *nog-1* and *rlp-24.2* cDNAs were amplified by RT-PCR and standard PCR, and then sub-cloned into pPD49.83 vectors. Following microinjections of these specified constructs, transgenic worms or their eggs were heat shocked at 30°C for 1 h over a 12-h interval.

RNA-mediated interference
-------------------------

A single colony of the RNAi construct-transformed bacteria was incubated overnight in Luria-Bertani (LB) broth with 100 μg/ml ampicillin. The next day, after the culture was diluted and grown for another 6 h, it was spread onto Nematode Growth Medium (NGM) plates containing 50 μg/ml ampicillin and 1 mM isopropyl-1-thio-β-D-galactopyranoside (IPTG). The plates were grown overnight at 20°C, allowing for the growth of a lawn of *E. coli* that expressed double-stranded RNAs (dsRNAs) of the target gene. Once ready, synchronized L4 worms were transferred and changed to fresh RNAi plates at 2-day intervals.

Phenotype analysis
------------------

The brood sizes and lifespans of *gfp, daf-2, daf-16, nog-1,* and *rlp-24.2* RNAi-treated worms were scored at 20°C. Individual worms were placed on RNAi bacterial feeding plates and allowed to self-fertilize at 20°C. The P0 worms were transferred to fresh plates at 12-h intervals for 4 subsequent days, and the number of progeny (F1) was counted. The life spans of the worms were assayed at 20°C. The L4 stage hermaphrodites were transferred to fresh plates daily or at 2-day intervals until they stopped laying eggs. If the worms failed to move when prodded or if they lacked pharyngeal pumping, the worms were scored as dead. If a worm crawled off the plate, it was excluded from the assay. The analyses were repeated three times. Statistical analyses were conducted using the software OASIS ([@b45-molcell-37-1-51-8]).

Sudan Black B staining
----------------------

L4 stage *C. elegans* were exposed to RNAi (*gfp, daf-2, daf-16,* and *nog-1*) feeding plates. After 5 days, the worms were removed from the plates and subsequently starved for 6 h. Following washing in M9, the worms were fixed with 1% paraformamide in M9. The worms were subjected to three freeze-thaw cycles and then dehydrated in 70% ethanol. For staining experiments, Sudan Black B stain was saturated in 70% ethanol and then added to the dehydrated worm samples. The worms were incubated overnight under mild shaking at room temperature followed by washing in 70% ethanol 4 times to eliminate any nonspecific dye. The supernatant was removed carefully followed by the addition of M9 buffer.

RESULTS AND DISCUSSION
======================

*C. elegans* nog-1 is an evolutionary conserved GTP-binding GTPase
------------------------------------------------------------------

Several GTP-binding proteins are well known for their critical roles in the signaling cascades of growth factors and hormones affecting the development of mammalian renal cells ([@b25-molcell-37-1-51-8]). It was also recently discovered that the chronic renal failure gene (*CRFG*) encodes a novel GTP-binding protein that expresses in the outer medulla of the kidney. CRFG products in humans and rats are known as orthologs of NOG-1. However, *C. elegans nog-1* has so far not been identified. Therefore, we compared candidates for NOG-1 (*T07A9.9: nog-1*) in *C. elegans* with other NOG1 proteins or homologs in humans, mice, and yeast. NOG1 belongs to the obg-like family of GTPases, which includes Obg, DRG, YyaF/Ychf, and Ygr210 ([@b28-molcell-37-1-51-8]). The Obg-like family of GTPases contains domains of GTP/Mg^2+^, Switch I, Switch II, and G1--G5 boxes. The GTP/Mg^2+^ binding domain is essential for GTPase activity ([@b6-molcell-37-1-51-8]), whereas Switch I and overlapping G2 box are essential effector sites ([@b6-molcell-37-1-51-8]; [@b10-molcell-37-1-51-8]). The alignment showed that NOG-1-specific domains are all conserved across the different animal groups ([Fig. 1](#f1-molcell-37-1-51-8){ref-type="fig"}). In addition, G2-specific threonine residues are also well conserved in these organisms ([Fig. 1](#f1-molcell-37-1-51-8){ref-type="fig"}; [@b10-molcell-37-1-51-8]). *C. elegans* NOG-1 shows 54.7% identity with human CRFG, 54% identity with mouse CRFG, and 42.3% identity with yeast NOG1. Given the high similarity with mammalian CRFGs and yeast NOG1, NOG-1 maybe a functionally conserved protein.

Expression and localization of *C. elegans nog-1*
-------------------------------------------------

To examine spatial and temporal expression patterns of NOG-1, plasmids of GFP transcriptional fusion (*Pnog-1::gfp*, [Figs. 2A](#f2-molcell-37-1-51-8){ref-type="fig"}--[2H](#f2-molcell-37-1-51-8){ref-type="fig"}) or GFP translational fusion (*Pnog-1::nog-1::gfp*; [Figs. 2I](#f2-molcell-37-1-51-8){ref-type="fig"}--[2K](#f2-molcell-37-1-51-8){ref-type="fig"}) were constructed and subsequently injected into wild-type young adults (N2 background). Analyses of the transgenic worms revealed that *Pnog-1::gfp* fluorescence was ubiquitous. Moreover, the expression was distinct throughout all stages of development, from early embryos to adult stages ([Figs. 2A](#f2-molcell-37-1-51-8){ref-type="fig"}--[2C](#f2-molcell-37-1-51-8){ref-type="fig"}). Green fluorescence expression was also prominent in the intestine ([Fig. 2D](#f2-molcell-37-1-51-8){ref-type="fig"}), germ cells ([Fig. 2E](#f2-molcell-37-1-51-8){ref-type="fig"}), body wall muscles ([Fig. 2F](#f2-molcell-37-1-51-8){ref-type="fig"}), pharynx, and excretory cells ([Fig. 2G](#f2-molcell-37-1-51-8){ref-type="fig"}). NOG-1 was expressed in the vulva and neurons as well ([Fig. 2H](#f2-molcell-37-1-51-8){ref-type="fig"}). This ubiquitous expression pattern may implicate a wide range of NOG-1 functions in the nematode. For further investigation, translational GFP (*Pnog-1::nog-1::gfp*) expression and nucleus staining (DAPI) experiments were performed. In intestinal cells, NOG-1 GFP accumulated specifically in the nucleolus ([Figs. 2I](#f2-molcell-37-1-51-8){ref-type="fig"} and [2J](#f2-molcell-37-1-51-8){ref-type="fig"}).

The GTP binding core (G domain) of GTPase consists of signature motifs (G1--G5) that are vital for GTP-binding and their functions. Conserved residues within the G domain of the mouse *nog1* gene were mutated. Among the mutants, a substitution of alanine for glycine in the Switch II segment of NOG1 (G224A) showed a prominent phenotype of cell growth inhibition. The G224A mutant displayed localized NOG1 accumulation in the nucleolus ([@b24-molcell-37-1-51-8]). Therefore, NOG-1 localization in *C. elegans* was performed using transgenic worms containing GFP translational fusion constructs that carried the NOG-1 GTP binding site defective mutation \[*Pnog-1::nog-1 (G225A):: gfp*\]. Analyses of the transgenics showed aggregated expression patterns of GFP ([Fig. 2K](#f2-molcell-37-1-51-8){ref-type="fig"}) in contrast to those of wild-type expression patterns ([Fig. 2J](#f2-molcell-37-1-51-8){ref-type="fig"}).

Moreover, G224A ectopic expression showed disruption of pre-60S assembly and arrest of cell proliferation ([@b24-molcell-37-1-51-8]). The precise glycine position of NOG-1 is required for the accurate maintenance of their molecular structure and proper conformational transition upon GTP-GDP exchanges. Our GFP translational expression data with a dominant-negative mutation further demonstrated the importance the glycine residue in NOG-1 in *C. elegans* and are consistent with the mammalian reports.

*nog-1* knockdown in *C. elegans* shows decreased brood size and growth rates
-----------------------------------------------------------------------------

To investigate *nog-1* function *in vivo*, control (gfp), *daf-2*, *daf-16*, and *nog-1* (for knockdown effect) RNAi bacteria were fed to wild type *C. elegans*. The brood sizes and growth rates of treated worms were examined ([Figs. 3A](#f3-molcell-37-1-51-8){ref-type="fig"} and [3B](#f3-molcell-37-1-51-8){ref-type="fig"}). Interestingly, the *nog-1* RNAi worms displayed an extremely reduced mean brood size (31.80 ± 17.37, n = 5 trials) in comparison to the control RNAi worms (244.2 ± 35.10, n = 5 trials), *daf-2* RNAi worms (200.6 ± 21.82, n = 5 trials), and *daf-16* RNAi worms (182.0 ± 16.94, n = 5 trials) ([Fig. 3A](#f3-molcell-37-1-51-8){ref-type="fig"}). In addition, the growth rate of *nog-1* knockdown worms was significantly slower than that of any of the other RNAi worms; the average time to reach adulthood in *nog-1* RNAi worms was approximately 90.06 h, whereas control RNAi worms reached adulthood at an average of 49.85 h ([Fig. 3B](#f3-molcell-37-1-51-8){ref-type="fig"}). These results suggest that *nog-1* is required for normal brood size and growth in *C. elegans*. Furthermore, it is plausible that the extremely slow growth of the *nog-1* RNAi worms may affect the brood size.

NOG-1 regulates life span through the insulin/IGF-1 pathway
-----------------------------------------------------------

It is known that insulin/IGF signaling regulates larval development and adult life span in *C. elegans* ([@b19-molcell-37-1-51-8]; [@b20-molcell-37-1-51-8]). In addition, the target of the rapamycin (TOR) pathway interacts with the insulin signaling pathway to regulate the development, metabolism, and life span of *C. elegans* ([@b18-molcell-37-1-51-8]). The NOG-1 protein is also an important component in ribosome biogenesis in association with TOR ([@b14-molcell-37-1-51-8]). Therefore, TOR/insulin pathways may be involved in regulating development and life span in *C. elegans via* NOG-1.To further test NOG-1 involvement in regulating the life span of *C. elegans*, we compared the life span of *nog-1* RNAi-treated worms with the life spans of control (gfp), *daf-2*, and *daf-16* knockdown worms. The mean life span of *nog-1* knockdown worms was 21.2 ± 0.40 days, which was significantly longer (15%) than that of control RNAi worms (18.46 ± 0.41 days) ([Fig. 4A](#f4-molcell-37-1-51-8){ref-type="fig"}). However, the extended life span of *nog-1* knockdown worms was not as prominent as that the life span of *daf-2* RNAi worms (29.85 ± 0.67 days).

Since *daf-16* is a well-known downstream target in the insulin/IGF-1 pathway and is negatively regulated by *daf-2*, *daf-16* RNAi worms showed extremely shortened life spans (12.9 ± 0.25 days). In order to test if NOG-1 may act in the insulin/IGF-1 pathway directly or indirectly, we performed similar experiments under a *daf-16 (mu86)* background. As expected, there were no significant differences among the three categories of treatment: control (12.21 ± 0.24 days), *daf-2* (13.2 ± 0.3 days), and *nog-1* (12.29 ± 0.27 days) ([Fig. 4B](#f4-molcell-37-1-51-8){ref-type="fig"}). The results further indicated that *daf-16* might be a downstream component of NOG-1-mediated extended life span.

Silent information regulator 2 protein (Sir2 or Sirtuin) is an NAD^+^-dependent protein deacetylase that has been identified in yeast, flies, and mammals, and recently in *C. elegans* as well ([@b4-molcell-37-1-51-8]; [@b7-molcell-37-1-51-8]). In *C. elegans*, Sirtuin gene (s*ir-2.1*) over-expression leads to life span extension and deletion of the gene shortens life span ([@b43-molcell-37-1-51-8]). To determine whether the Sir-2.1-mediated pathway is involved in regulating life span *via* NOG-1 in *C. elegans*, the life span assay was performed under a *sir-2.1(ok434)* background ([Fig. 4C](#f4-molcell-37-1-51-8){ref-type="fig"}). Even in the *sir-2.1(ok434)* background, *nog-1* RNAi-treated worms showed significantly increased life spans compared to the control (gfp RNAi): 19.35 ± 0.4 and 15.89 ± 0.3 days, respectively. Therefore, NOG-1-mediated life span extension may be independent of the Sir-2.1 pathway.

NOG-1 associates with RLP-24.2 (Rlp24p) to affect life span of *C. elegans*
---------------------------------------------------------------------------

NOG-1 is essential for the maturation of 60S ribosome particles. Specifically, it is required for 35S rRNA processing, which is an early step of ribosome biosynthesis ([@b17-molcell-37-1-51-8]). However, NOG-1 is distributed throughout the nucleus and is also known to associate with a number of 60S RPs. Yeast ribosomal like protein 24 (Rlp24p) encodes a large ribosomal subunit L24 protein; yeast Rlp24 is essential for both early and late stages of 60S ribosome biogenesis and is known to interact with NOG-1, both genetically and physically ([@b13-molcell-37-1-51-8]; [@b37-molcell-37-1-51-8]).

We predicted that over-expressing *nog-1* or *rlp-24.2* in *C. elegans* may alter its life span. Thus, we generated *nog-1* and/or *rlp-24.2* over-expression constructs with heat shock promoters (see "Materials and Methods"). Transgenic worms (synchronous L4 stage larvae) or their eggs were given heat shock and subsequently examined for the effects of the over-expression of desired genes in relation to the life span of the worms.

Either *nog-1* or *rlp-24.2* over-expression from embryos resulted in decreased adult longevity compared to the control (*gfp*; [Fig. 5A](#f5-molcell-37-1-51-8){ref-type="fig"}). Interestingly *nog-1* and *rlp-24.2* double over-expression displayed a further decrease in life span. On the other hand, the results from over-expression in L4 stages showed a similar pattern but to a lesser degree ([Fig. 5B](#f5-molcell-37-1-51-8){ref-type="fig"}). Even though the differences between the controls and *nog-1* over-expression from L4 were minimal, the cumulative decrease in double over-expression indicates NOG-1 involvement in longevity. In addition, the decline in longevity in *nog-1* and *rlp-24.2* over-expression worms indicates physical and functional interactions between NOG-1 and RLP-24.2. However, *nog-*1 and *rlp-24.*2 double RNAi treatment showed no additive increase of longevity (data not shown).

NOG-1 influences fat storage in *C. elegans*
--------------------------------------------

*C. elegans* has recently emerged as a convenient model for studying the *in vivo* mechanisms of fat storage, which occurs in the worm's intestine ([@b27-molcell-37-1-51-8]). Moreover, there are several studies showing that fat storage is related to the conserved insulin/IGF pathway and the mammalian target of rapamycin (mTOR, *let-363* in *C. elegans*) signaling pathway in *C. elegans* ([@b1-molcell-37-1-51-8]; [@b32-molcell-37-1-51-8]; [@b46-molcell-37-1-51-8]).

It is well known that *C. elegans* insulin receptor (*daf-2*) mutants quite often display temperature-sensitive constitutive dauer formation, and also a non-dauer-inducing condition during the availability of adequate food. When *daf-2* mutants were allowed to grow at permissive temperatures, the adult worm exhibited increased lifespan and fat stores, bypassing the dauer stage ([@b19-molcell-37-1-51-8]; [@b20-molcell-37-1-51-8]). These *daf-2* mutants further depend on DAF-16, a downstream FOXO transcription factor ([@b2-molcell-37-1-51-8]; [@b33-molcell-37-1-51-8]), for regulating lifespan and development.

Keeping in mind the roles of TOR/insulin pathways in regulating development and life span in worms, as well as fat storage, we therefore hypothesized that NOG-1 might play a role in the mechanism of fat storage in *C. elegans via* the insulin/IGF pathway. In order to examine this, we used a fat soluble dye for staining, Sudan Black B, as a method for visualization of fat storage since Sudan Black B staining is an effective and simple way to reflect the whole fat content in organisms in place of CARS microscopy ([@b46-molcell-37-1-51-8]). These results were consistent with those of the life span assays, as Sudan Black B staining experiments revealed increased fat stores in *nog-1* knockdown animals that had increased life spans ([Fig. 6D](#f6-molcell-37-1-51-8){ref-type="fig"}) compared to the control RNAi-treated worms ([Fig. 6A](#f6-molcell-37-1-51-8){ref-type="fig"}). This high fat store content was also found in the long-lived *daf-2-*RNAi treated worms ([Fig. 6B](#f6-molcell-37-1-51-8){ref-type="fig"}), whereas *daf-16* RNAi-treated worms displayed a relatively decreased fat storage compared to the control RNAi worms, which is an observation consistent with its shorter life span ([Fig. 6C](#f6-molcell-37-1-51-8){ref-type="fig"}).

To further test the role of NOG-1 in fat storage *via* the insulin/IGF pathway, *nog-1* RNAi bacteria were fed to *daf-16(mu86)* mutants. The *nog-1* RNAi/*daf-16*(*mu86*) worms ([Fig. 6E](#f6-molcell-37-1-51-8){ref-type="fig"}) showed decreased staining patterns compared to the *nog-1* RNAi as well as *daf-16* RNAi-treated worms. These results suggest that NOG-1 regulates fat storage in association with life span *via* the insulin/IGF signaling pathway.

In summary, the nucleolar GTPase NOG-1 in *C. elegans* may have essential functions in growth, development, life span, and fat storage. Specifically, life span and fat storage regulation by NOG-1 are involved *via* the insulin/IGF pathways.
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![*C. elegans NOG-1* is a conserved protein. Amino acid sequence alignment of NOG-1 among *C. elegans* (*C. elegans* NOG-1; accession no. O44411), human CRFG (*H. sapiens* CRFG; accession no. Q9BZE4), mouse CRFG (*M. musculus* CRFG; accession no. Q99ME9), and yeast NOG1(*S. cerevisiae* NOG1, accession no. Q02892) by PRALINE program. Sequence similarities among NOG-1/CRFG homologues are represented by different colored boxes (from red to blue, high conserved to less conserved). Black box, G1 to G5 boxes; black upper line, Switch I and Switch II region; \#, GTP/Mg^2+^ binding; black arrow, G225A (G224A in mouse).](molcell-37-1-8-f1){#f1-molcell-37-1-51-8}

![Expression and localization of *C. elegans nog-1*. GFP transcriptional fusion constructs (*Pnog-1::gfp*) and NOG-1 GFP translational fusion constructs (*Pnog-1::nog-1::gfp*) were injectted into wild-type young adults. GFP expressions were examined and photographed in the transgenic worms under a fluorescence microscope. *Pnog-1:: gfp* fluorescence was expressed from early embryo stages to adult stages (A, embryo; B, larva stage; C, adult). The expression was observed in intestine (D), germ cells (arrow) and excretory cells (arrowhead) (E), body wall muscles (F), in pharynx (arrow) and excretory cells (arrowhead) (G) and in vulva (arrow), and neurons \[arrowhead, (H)\]. Nucleus NOG-1::GFP localization in intestine cells; DAPI staining (I), NOG-1::GFP localization in nucleolus (J), and NOG-1G225A (GTP binding site defect) localization in nucleolus (K). (I) and (J) are obtained from the same cell. Scale bar, (A--H), 50 μm; (I--K), 10 μm.](molcell-37-1-8-f2){#f2-molcell-37-1-51-8}

![Brood size and growth rate in *nog-1* knockdown animals. (A) Brood sizes of control (gfp RNAi), *daf-2*, *daf-16*, and *nog-1* RNAi treated worms (n = 20, average of 5 trials). (B) Growth rates of control (gfp RNAi), *daf-2*, *daf-16*, and *nog-1* RNAi treated worms (n = 20, average of 5 trials).](molcell-37-1-8-f3){#f3-molcell-37-1-51-8}

![NOG-1 regulates life span *via* insulin/IGF-1 pathway. Life span analyses at 20°C. (A) The average life spans of control (gfp RNAi), *daf-2*, *daf-16* and *nog-1* RNAi treated worms in N2 background (n = 172, 122, 185, and 182 respectively). (B) The average life spans in *daf-16(mu86)* background (n = 126, 119, 135, and 155 respectively). (C) The average life spans in *sir-2.1(ok434)* (n = 160, 151, 150, and 133 respectively).](molcell-37-1-8-f4){#f4-molcell-37-1-51-8}

![Over-expression of *nog-1*. Control (gfp), *nog-1*, *rlp-24.2*, and *nog-1and rlp-24.2* (double) over-expression constructs with heat shock promoters were used to create transgenic worms (see "Materials and Methods"). The transgenic worms were exposed to heat shock starting from egg stage (A), and from L4 stages (B) continuously. n = approximately 100.](molcell-37-1-8-f5){#f5-molcell-37-1-51-8}

![Fat accumulation assay of *nog-1* knockdown worms. Sudan Black B staining was performed for control (*gfp*, A), *daf-2* (B), *daf-16* (C), *nog-1* (D) RNAi treated wild type worms (N2 background), and (E) *nog-1* RNAi treatment in *daf-16(mu86)* mutants.](molcell-37-1-8-f6){#f6-molcell-37-1-51-8}
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